Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
DH

Diana Hernández‐Romero

General Cardiology
Instituto Murciano de Investigación Biosanitaria

About

Diana Hernández‐Romero works in General Cardiology affiliated with Instituto Murciano de Investigación Biosanitaria.

Diana Hernández-Romero is an Associate Professor in the Department of Health Sciences at the University of Murcia. She serves as a postdoctoral researcher in the Department of Cardiology at Hospital Clínico Universitario Virgen de la Arrixaca and is affiliated with the Instituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca). Her research includes studies on biomarkers in cardiovascular diseases and forensic applications in cardiac pathology.

Research focus

Atrial Fibrillation ManagementHypertrophic Cardiomyopathy BiomarkersAntiplatelet Therapy in Cardiovascular DiseasesVenous Thromboembolism ManagementCardiac Remodeling

Impact

78 pubs · 1,767 cites · h-index 23

Training

  • PhD

    Universidad de Murcia

    2006

Affiliations

Publications

Recent publications by Diana Hernández‐Romero

  1. Application of artificial intelligence in the determination of the postmortem interval: Systematic review of the literature and metaanalysisForensic Science Medicine and Pathology · Fri,
  2. Proteomics in Cardiovascular Deaths, a Postmortem Pilot Study: The Diagnostic Efficacy of α-1 Antitrypsin and Apolipoprotein A-IV in Ischemic and Congestive DeathsDiagnostics · Thu,
  3. Endothelial activation, cell-cell interactions, and inflammatory pathways in postoperative atrial fibrillation following cardiac surgeryBiomedical Journal · Tue,
  4. Molecular mechanisms of postoperative atrial fibrillation in patients with obstructive sleep apneaThe FASEB Journal · Fri,
  5. Diagnostic Application of Postmortem Cardiac Troponin I Pericardial Fluid/Serum Ratio in Sudden Cardiac DeathSHILAP Revista de lepidopterología · Tue,
  6. Proteomics in Deaths by Drowning: Diagnostic Efficacy of Apolipoprotein A1 and α-1 Antitrypsin, Pilot StudyDiagnostics · Thu,
  7. Galectin-3 and β-trace protein concentrations are higher in clinically unaffected patients with Fabry diseaseScientific Reports · Wed,
  8. Inhibition of enzymes involved in collagen cross‐linking reduces vascular smooth muscle cell calcificationThe FASEB Journal · Fri,
  9. Does von Willebrand factor improve the predictive ability of current risk stratification scores in patients with atrial fibrillation?Scientific Reports · Mon,
  10. Galectin-3 as a marker of interstitial atrial remodelling involved in atrial fibrillationScientific Reports · Thu,